Top

Published in:

01-05-2019 | Parkinson's Disease | Neurology and Preclinical Neurological Studies - Original Article

Microglia activation induces oxidative injury and decreases SIRT3 expression in dopaminergic neuronal cells

Authors: De-Qi Jiang, Yan-Jiao Ma, Yong Wang, Hai-Xiao Lu, Shu-Hui Mao, Shi-Hua Zhao

Published in: Journal of Neural Transmission | Issue 5/2019

Abstract

Microglia activation-mediated neuroinflammation plays an important role in the progression of Parkinson’s disease (PD). However, effects of microglia activation on dopaminergic neuronal cell (DAC) fate are still poorly understood. The objective of this study was to explore the neurotoxic effects of microglia activation-mediated oxidative injury in DACs and its possible mechanisms. In the present study, microglia-DACs co-culture systems (murine BV-2 and MN9D cells, or primary microglia and mesencephalic neurons) were used to display the crosstalk between both cell types. The cytotoxicity of lipopolysaccharide-induced microglia activation led to the accumulation of intracellular reactive oxygen species, increased cell apoptosis rate, reduced number of DACs, concomitant to cell cycle arrest at G₁ phase. Molecular mechanisms of apoptosis caused by microglia activation-induced oxidative injury included the increased opening of mitochondrial permeability transition pore and enhanced membrane potential depolarization in MN9D cells, down-regulation of Bcl-2 and up-regulation of Bax, caspase-3 expression in DACs. In addition, microglia activation made a significant reduction of SIRT3 and superoxide dismutase 2 gene expression in DACs. Taken together, these data imply that microglia activation promotes cell apoptosis through mitochondrial pathway and decreases SIRT3 expression in DACs, which may provide some support for PD progression promoted by neuroinflammation.

Alageel A, Tomasi J, Tersigni C, Brietzke E, Zuckerman H, Subramaniapillai M, Lee Y, Iacobucci M, Rosenblat JD, Mansur RB, McIntyre RS (2018) Evidence supporting a mechanistic role of sirtuins in mood and metabolic disorders. Prog Neuropsychopharmacol Biol Psychiatry 86:95–101. https://doi.org/10.1016/j.pnpbp.2018.05.017 CrossRefPubMed

Cho CH, Kim EA, Kim J, Choi SY, Yang SJ, Cho SW (2016) N-Adamantyl-4-methylthiazol-2-amine suppresses amyloid beta-induced neuronal oxidative damage in cortical neurons. Free Radic Res 50(6):678–690. https://doi.org/10.3109/10715762.2016.1167277 CrossRefPubMed

Di Lisa F, Menabo R, Canton M, Barile M, Bernardi P (2001) Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD⁺ and is a causative event in the death of myocytes in postischemic reperfusion of the heart. J Biol Chem 276(4):2571–2575. https://doi.org/10.1074/jbc.M006825200 CrossRefPubMed

Gan P, Xia Q, Hang G, Zhou Y, Qian X, Wang X, Ding L (2018) Knockdown of cathepsin D protects dopaminergic neurons against neuroinflammation-mediated neurotoxicity through inhibition of NF-kappaB signalling pathway in Parkinson’s disease model. Clin Exp Pharmacol Physiol. https://doi.org/10.1111/1440-1681.13052 CrossRefPubMed

Ganguly G, Chakrabarti S, Chatterjee U, Saso L (2017) Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer’s disease and Parkinson’s disease. Drug Des Dev Ther 11:797–810. https://doi.org/10.2147/dddt.s130514 CrossRef

García-Domínguez I, Vesela K, Garcia-Revilla J, Carrillo-Jimenez A, Roca-Ceballos MA, Santiago M, de Pablos RM, Venero JL (2018) Peripheral inflammation enhances microglia response and nigral dopaminergic cell death in an in vivo MPTP model of Parkinson’s disease. Front Cell Neurosci 12:398. https://doi.org/10.3389/fncel.2018.00398 CrossRefPubMedPubMedCentral

Huang B, Liu J, Ju C, Yang D, Chen G, Xu S, Zeng Y, Yan X, Wang W, Liu D, Fu S (2017) Licochalcone A prevents the loss of dopaminergic neurons by inhibiting microglial activation in lipopolysaccharide (LPS)-induced Parkinson’s disease models. Int J Mol Sci 18(10):E2043. https://doi.org/10.3390/ijms18102043 CrossRefPubMed

Jiang B, Du J, Liu JH, Bao YM, An LJ (2008) Catalpol attenuates the neurotoxicity induced by beta-amyloid(1-42) in cortical neuron-glia cultures. Brain Res 1188:139–147. https://doi.org/10.1016/j.brainres.2007.07.105 CrossRefPubMed

Jiang DQ, Wei MD, Wang KW, Lan YX, Zhu N, Wang Y (2016) Nicotine contributes to the neural stem cells fate against toxicity of microglial-derived factors induced by Abeta via the Wnt/beta-catenin pathway. Int J Neurosci 126(3):257–268. https://doi.org/10.3109/00207454.2015.1008696 CrossRefPubMed

Jiang DQ, Wang Y, Li MX, Ma YJ, Wang Y (2017) SIRT3 in neural stem cells attenuates microglia activation-induced oxidative stress injury through mitochondrial pathway. Front Cell Neurosci 11:7. https://doi.org/10.3389/fncel.2017.00007 CrossRefPubMedPubMedCentral

Kurundkar D, Kurundkar AR, Bone NB, Becker EJ Jr, Liu W, Chacko B, Darley-Usmar V, Zmijewski JW, Thannickal VJ (2019) SIRT3 diminishes inflammation and mitigates endotoxin-induced acute lung injury. JCI Insight 4(1):120722. https://doi.org/10.1172/jci.insight.120722 CrossRefPubMed

Lee J, Kim Y, Liu T, Hwang YJ, Hyeon SJ, Im H, Lee K, Alvarez VE, McKee AC, Um SJ, Hur M, Mook-Jung I, Kowall NW, Ryu H (2018) SIRT3 deregulation is linked to mitochondrial dysfunction in Alzheimer’s disease. Aging Cell 17(1):e12679. https://doi.org/10.1111/acel.12679 CrossRef

Liu L, Peritore C, Ginsberg J, Kayhan M, Donmez G (2015) SIRT3 attenuates MPTP-induced nigrostriatal degeneration via enhancing mitochondrial antioxidant capacity. Neurochem Res 40(3):600–608. https://doi.org/10.1007/s11064-014-1507-8 CrossRefPubMed

Liu J, Li D, Zhang T, Tong Q, Ye RD, Lin L (2017) SIRT3 protects hepatocytes from oxidative injury by enhancing ROS scavenging and mitochondrial integrity. Cell Death Dis 8(10):e3158. https://doi.org/10.1038/cddis.2017.564 CrossRefPubMedPubMedCentral

Liu C, Zhang CW, Lo SQ, Ang ST, Chew KCM, Yu D, Chai BH, Tan B, Tsang F, Tai YK, Tan BWQ, Liang MC, Tan HT, Tang JY, Lai MKP, Chua JJE, Chung MCM, Khanna S, Lim KL, Soong TW (2018a) S-Nitrosylation of divalent metal transporter 1 enhances iron uptake to mediate loss of dopaminergic neurons and motoric deficit. J Neurosci 38(39):8364–8377. https://doi.org/10.1523/jneurosci.3262-17.2018 CrossRefPubMedPubMedCentral

Liu J, Yan W, Zhao X, Jia Q, Wang J, Zhang H, Liu C, He K, Sun Z (2018b) Sirt3 attenuates post-infarction cardiac injury via inhibiting mitochondrial fission and normalization of AMPK-Drp1 pathways. Cell Signal 53:1–13. https://doi.org/10.1016/j.cellsig.2018.09.009 CrossRefPubMed

Moschen AR, Wieser V, Gerner RR, Bichler A, Enrich B, Moser P, Ebenbichler CF, Kaser S, Tilg H (2013) Adipose tissue and liver expression of SIRT1, 3, and 6 increase after extensive weight loss in morbid obesity. J Hepatol 59(6):1315–1322. https://doi.org/10.1016/j.jhep.2013.07.027 CrossRef

Ogura Y, Kitada M, Monno I, Kanasaki K (2018) Renal mitochondrial oxidative stress is enhanced by the reduction of Sirt3 activity, in Zucker diabetic fatty rats. Redox Rep 23(1):153–159. https://doi.org/10.1080/13510002.2018.1487174 CrossRefPubMed

Porter LC, Franczyk MP, Pietka T, Yamaguchi S, Lin JB, Sasaki Y, Verdin E, Apte RS, Yoshino J (2018) NAD(+)-dependent deacetylase SIRT3 in adipocytes is dispensable for maintaining normal adipose tissue mitochondrial function and whole body metabolism. Am J Physiol Endocrinol Metab 315(4):E520–E530. https://doi.org/10.1152/ajpendo.00057.2018 CrossRefPubMed

Puspita L, Chung SY, Shim JW (2017) Oxidative stress and cellular pathologies in Parkinson’s disease. Mol Brain 10(1):53. https://doi.org/10.1186/s13041-017-0340-9 CrossRefPubMedPubMedCentral

Qadir MI, Anwar S (2017) Sirtuins in brain aging and neurological disorders. Crit Rev Eukaryot Gene Expr 27(4):321–329. https://doi.org/10.1615/CritRevEukaryotGeneExpr.2017019532 CrossRefPubMed

Qiu X, Brown K, Hirschey MD, Verdin E, Chen D (2010) Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab 12(6):662–667. https://doi.org/10.1016/j.cmet.2010.11.015 CrossRefPubMed

Qu M, Zhou Z, Chen C, Li M, Pei L, Yang J, Wang Y, Li L, Liu C, Zhang G, Yu Z, Wang D (2012) Inhibition of mitochondrial permeability transition pore opening is involved in the protective effects of mortalin overexpression against beta-amyloid-induced apoptosis in SH-SY5Y cells. Neurosci Res 72(1):94–102. https://doi.org/10.1016/j.neures.2011.09.009 CrossRefPubMed

Quan Y, Xia L, Shao J, Yin S, Cheng CY, Xia W, Gao WQ (2015) Adjudin protects rodent cochlear hair cells against gentamicin ototoxicity via the SIRT3-ROS pathway. Sci Rep 5:8181. https://doi.org/10.1038/srep08181 CrossRefPubMedPubMedCentral

Schapira AH, Jenner P (2011) Etiology and pathogenesis of Parkinson’s disease. Mov Disord 26(6):1049–1055. https://doi.org/10.1002/mds.23732 CrossRefPubMed

Shi H, Deng HX, Gius D, Schumacker PT, Surmeier DJ, Ma YC (2017) Sirt3 protects dopaminergic neurons from mitochondrial oxidative stress. Cell Death Dis 26(10):1915–1926. https://doi.org/10.1093/hmg/ddx100 CrossRef

Sun Q, Jia N, Wang W, Jin H, Xu J, Hu H (2014) Protective effects of astragaloside IV against amyloid beta1-42 neurotoxicity by inhibiting the mitochondrial permeability transition pore opening. PLoS One 9(6):e98866. https://doi.org/10.1371/journal.pone.0098866 CrossRefPubMedPubMedCentral

Wang X, Chen S, Ma G, Ye M, Lu G (2005) Involvement of proinflammatory factors, apoptosis, caspase-3 activation and Ca²⁺ disturbance in microglia activation-mediated dopaminergic cell degeneration. Mech Ageing Dev 126(12):1241–1254. https://doi.org/10.1016/j.mad.2005.06.012 CrossRefPubMed

Wang XQ, Shao Y, Ma CY, Chen W, Sun L, Liu W, Zhang DY, Fu BC, Liu KY, Jia ZB, Xie BD, Jiang SL, Li RK, Tian H (2014) Decreased SIRT3 in aged human mesenchymal stromal/stem cells increases cellular susceptibility to oxidative stress. J Cell Mol Med 18(11):2298–2310. https://doi.org/10.1111/jcmm.12395 CrossRefPubMedPubMedCentral

Wang Y, Lin J, Chen QZ, Zhu N, Jiang DQ, Li MX, Wang Y (2015) Overexpression of mitochondrial Hsp75 protects neural stem cells against microglia-derived soluble factor-induced neurotoxicity by regulating mitochondrial permeability transition pore opening in vitro. Int J Mol Med 36(6):1487–1496. https://doi.org/10.3892/ijmm.2015.2380 CrossRefPubMedPubMedCentral

Wang Y, He J, Liao M, Hu M, Li W, Ouyang H, Wang X, Ye T, Zhang Y, Ouyang L (2018) An overview of Sirtuins as potential therapeutic target: structure, function and modulators. Eur J Med Chem 161:48–77. https://doi.org/10.1016/j.ejmech.2018.10.028 CrossRefPubMed

Xiang XY, Kang JS, Yang XC, Su J, Wu Y, Yan XY, Xue YN, Xu Y, Liu YH, Yu CY, Zhang ZC, Sun LK (2016) SIRT3 participates in glucose metabolism interruption and apoptosis induced by BH3 mimetic S1 in ovarian cancer cells. Int J Oncol 49(2):773–784. https://doi.org/10.3892/ijo.2016.3552 CrossRefPubMed

Xu H, Hertzel AV, Steen KA, Bernlohr DA (2016) Loss of fatty acid binding protein 4/aP2 reduces macrophage inflammation through activation of SIRT3. Mol Endocrinol 30(3):325–334. https://doi.org/10.1210/me.2015-1301 CrossRefPubMedPubMedCentral

Ye J, Jiang Z, Chen X, Liu M, Li J, Liu N (2016) Electron transport chain inhibitors induce microglia activation through enhancing mitochondrial reactive oxygen species production. Exp Cell Res 340(2):315–326. https://doi.org/10.1016/j.yexcr.2015.10.026 CrossRefPubMed

Ye J, Jiang Z, Chen X, Liu M, Li J, Liu N (2017) The role of autophagy in pro-inflammatory responses of microglia activation via mitochondrial reactive oxygen species in vitro. J Neurochem 142(2):215–230. https://doi.org/10.1111/jnc.14042 CrossRefPubMed

Zeng L, Yang Y, Hu Y, Sun Y, Du Z, Xie Z, Zhou T, Kong W (2014) Age-related decrease in the mitochondrial sirtuin deacetylase Sirt3 expression associated with ROS accumulation in the auditory cortex of the mimetic aging rat model. PLoS One 9(2):e88019. https://doi.org/10.1371/journal.pone.0088019 CrossRefPubMedPubMedCentral

Zeng H, He X, Tuo QH, Liao DF, Zhang GQ, Chen JX (2016) LPS causes pericyte loss and microvascular dysfunction via disruption of Sirt3/angiopoietins/Tie-2 and HIF-2alpha/Notch3 pathways. Sci Rep 6:20931. https://doi.org/10.1038/srep20931 CrossRefPubMedPubMedCentral

Zhang F, Wang YY, Yang J, Lu YF, Liu J, Shi JS (2013) Tetrahydroxystilbene glucoside attenuates neuroinflammation through the inhibition of microglia activation. Oxid Med Cell Longev 2013:680545. https://doi.org/10.1155/2013/680545 CrossRefPubMedPubMedCentral

Zhang X, Ren X, Zhang Q, Li Z, Ma S, Bao J, Li Z, Bai X, Zheng L, Zhang Z, Shang S, Zhang C, Wang C, Cao L, Wang Q, Ji J (2016) PGC-1alpha/ERRalpha-Sirt3 pathway regulates DAergic neuronal death by directly deacetylating SOD2 and ATP synthase beta. Antioxid Redox Signal 24(6):312–328. https://doi.org/10.1089/ars.2015.6403 CrossRefPubMedPubMedCentral

Zheng J, Shi L, Liang F, Xu W, Li T, Gao L, Sun Z, Yu J, Zhang J (2018) Sirt3 ameliorates oxidative stress and mitochondrial dysfunction after intracerebral hemorrhage in diabetic rats. Front Neurosci 12:414. https://doi.org/10.3389/fnins.2018.00414 CrossRefPubMedPubMedCentral

Title: Microglia activation induces oxidative injury and decreases SIRT3 expression in dopaminergic neuronal cells
Authors: De-Qi Jiang
Yan-Jiao Ma
Yong Wang
Hai-Xiao Lu
Shu-Hui Mao
Shi-Hua Zhao
Publication date: 01-05-2019
Publisher: Springer Vienna
Keyword: Parkinson's Disease
Published in: Journal of Neural Transmission / Issue 5/2019
Print ISSN: 0300-9564
Electronic ISSN: 1435-1463
DOI: https://doi.org/10.1007/s00702-019-02005-z

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Microglia activation induces oxidative injury and decreases SIRT3 expression in dopaminergic neuronal cells

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2019

Subjective and physiological stress measurement in a multiple sclerosis sample and the relation with executive functions performance

Abstracts of the German Congress on Parkinson’s Disease and Movement Disorders (Deutscher Kongress für Parkinson und Bewegungsstörungen), 7–9 March 2019, Düsseldorf, Germany

Disease duration in E200K familial Creutzfeldt–Jakob disease is correlated with clinical, radiological, and laboratory variables

Actigraphy studies and clinical and biobehavioural correlates in schizophrenia: a systematic review

Digit ratio (2D:4D) in relation to substance and computer use: a meta-analysis

Correction to: Tyrosine-hydroxylase immunoreactivity in the mouse transparent brain and adrenal glands